Marble Harbor Investment Counsel, LLC Amgen Inc Transaction History

Marble Harbor Investment Counsel, LLC

$919 Million
Q3 2025

A detailed history of Marble Harbor Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Marble Harbor Investment Counsel, LLC holds 2,294 shares of AMGN stock, worth $783,882. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,294

Previous 2,252 1.87%

Holding current value

$783,882

Previous $628,000 3.03%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$271.18 - $309.22 $11,389 - $12,987	42 Added 1.87%	2,294 $647,000
Q4 2024 Feb 07, 2025	SELL	$258.78 - $328.31 $38,816 - $49,246	-150 Reduced 6.24%	2,252 $586,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $19,627 - $23,692	-73 Reduced 2.95%	2,402 $682,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $59,691 - $74,108	273 Added 12.4%	2,475 $665,000
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $21,427 - $25,337	-100 Reduced 4.34%	2,202 $488,000

Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $41,225 - $52,381	180 Added 8.48%	2,302 $604,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $46,142 - $51,348	-200 Reduced 8.61%	2,122 $516,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $87,708 - $97,028	400 Added 20.81%	2,322 $561,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 2.54%	1,922 $409,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $152,994 - $169,736	-655 Reduced 24.93%	1,972 $481,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $21,638 - $25,767	100 Added 3.96%	2,627 $604,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $174 - $208	-1 Reduced 0.04%	2,527 $489,000
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $7,501 - $8,793	-45 Reduced 1.75%	2,528 $466,000
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $4,460 - $5,206	-25 Reduced 0.96%	2,573 $501,000
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $9,264 - $10,444	50 Added 1.96%	2,598 $539,000
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $16,605 - $18,651	100 Added 4.08%	2,548 $470,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $211,787 - $247,500	-1,250 Reduced 33.8%	2,448 $417,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $618,638 - $706,318	3,698	3,698 $689,000

Others Institutions Holding AMGN

# of Institutions

3,335

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marble Harbor Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marble Harbor Investment Counsel, LLC with notifications on news.

Account

Marble Harbor Investment Counsel, LLC Amgen Inc Transaction History